Biohaven Ltd (BHVN)

$8.30 +0.22 (2.72%)
Market Cap 878.60M
Revenue (ttm) 0.00
Net Income (ttm) -846.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.91
Volume 4,821,600
Avg Vol 3,728,290
Day's Range N/A - N/A
Shares Out 105.86M
Stochastic %K 11%
Beta 1.10
Analysts Strong Sell
Price Target $25.44

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 404 0410
Address:
215 Church Street, New Haven, United States
ignoreo
ignoreo Nov. 14 at 9:50 PM
$BHVN setting these funds aside to sue. theyve been sued before, they will be sued again. whatever it takes. they will pay me back for my funds too after i sue https://rosenlegal.com/case/biohaven-ltd/
0 · Reply
Reneejordan001
Reneejordan001 Nov. 14 at 8:27 PM
$BHVN 👇 🤣🤣🥴🙄🤡
0 · Reply
Reneejordan001
Reneejordan001 Nov. 14 at 7:22 PM
$BHVN Take your loss and move on or are you just trolling? I'm going with the latter part
1 · Reply
ignoreo
ignoreo Nov. 14 at 5:01 PM
$BHVN "JANUS HENDERSON GROUP PLC" WHO IS THIS NO NAME POS NO NAME POS IS THE --only-- TUTE THEY COULD DUPE SO THEY HAD TO FUND THEIR COMPANY WITH THE $$ THEY STOLE PREVIOUSLY SCAM COMPANY
0 · Reply
ignoreo
ignoreo Nov. 14 at 5:00 PM
$BHVN WORTHLESS STOCK RUINING MY LIFE WORTHLESS WORTHLESS MARKET UP 3%, ITS STILL DOWN??? DOWN 50% AND DOWN MORE?? WTF SCAM COMPANY
0 · Reply
_Verticality
_Verticality Nov. 14 at 8:46 AM
$BHVN $TNXP $MOBX $XLO ;
0 · Reply
Timefortendies77
Timefortendies77 Nov. 13 at 11:55 PM
$BHVN I'm in after MDD and before Epilepsy read out.
1 · Reply
Timefortendies77
Timefortendies77 Nov. 13 at 11:54 PM
$BHVN Looks like they did a successful raise--so maybe this will hold them over for awhile. Anyone estimate what this does with the cash burn? We can make it through Epilepsy trials?
1 · Reply
Reneejordan001
Reneejordan001 Nov. 13 at 10:11 PM
$BHVN Offering is closed!!
0 · Reply
BapoRothstein
BapoRothstein Nov. 13 at 9:02 PM
$BHVN Lol. My cost is sub 8.
0 · Reply
Latest News on BHVN
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Nov 13, 2025, 4:05 PM EST - 2 days ago

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

Nov 12, 2025, 3:54 PM EST - 3 days ago

Biohaven Q3 Earnings: Falling Back To Earth With A Thud

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Nov 12, 2025, 8:10 AM EST - 3 days ago

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

FLNG

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Nov 12, 2025, 7:15 AM EST - 3 days ago

Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Biohaven Announces Proposed Public Offering of Common Shares

Nov 11, 2025, 4:05 PM EST - 4 days ago

Biohaven Announces Proposed Public Offering of Common Shares

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Nov 10, 2025, 6:58 AM EST - 5 days ago

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Nov 5, 2025, 12:53 PM EST - 10 days ago

Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection

Biohaven shares plunge after US FDA declines to approve brain disorder drug

Nov 5, 2025, 10:02 AM EST - 10 days ago

Biohaven shares plunge after US FDA declines to approve brain disorder drug

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

Nov 4, 2025, 8:06 PM EST - 11 days ago

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Sep 10, 2025, 3:39 PM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Sep 6, 2025, 10:03 AM EDT - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 28, 2025, 6:55 PM EDT - 2 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

Aug 25, 2025, 8:00 AM EDT - 2 months ago

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 22, 2025, 10:05 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

Aug 11, 2025, 7:00 AM EDT - 3 months ago

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Aug 4, 2025, 8:45 AM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Jul 18, 2025, 12:06 PM EDT - 4 months ago

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Jul 18, 2025, 12:00 PM EDT - 4 months ago

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jul 15, 2025, 10:46 AM EDT - 4 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Jun 10, 2025, 2:00 PM EDT - 5 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

May 29, 2025, 7:01 AM EDT - 6 months ago

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

May 28, 2025, 3:00 PM EDT - 6 months ago

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

ignoreo
ignoreo Nov. 14 at 9:50 PM
$BHVN setting these funds aside to sue. theyve been sued before, they will be sued again. whatever it takes. they will pay me back for my funds too after i sue https://rosenlegal.com/case/biohaven-ltd/
0 · Reply
Reneejordan001
Reneejordan001 Nov. 14 at 8:27 PM
$BHVN 👇 🤣🤣🥴🙄🤡
0 · Reply
Reneejordan001
Reneejordan001 Nov. 14 at 7:22 PM
$BHVN Take your loss and move on or are you just trolling? I'm going with the latter part
1 · Reply
ignoreo
ignoreo Nov. 14 at 5:01 PM
$BHVN "JANUS HENDERSON GROUP PLC" WHO IS THIS NO NAME POS NO NAME POS IS THE --only-- TUTE THEY COULD DUPE SO THEY HAD TO FUND THEIR COMPANY WITH THE $$ THEY STOLE PREVIOUSLY SCAM COMPANY
0 · Reply
ignoreo
ignoreo Nov. 14 at 5:00 PM
$BHVN WORTHLESS STOCK RUINING MY LIFE WORTHLESS WORTHLESS MARKET UP 3%, ITS STILL DOWN??? DOWN 50% AND DOWN MORE?? WTF SCAM COMPANY
0 · Reply
_Verticality
_Verticality Nov. 14 at 8:46 AM
$BHVN $TNXP $MOBX $XLO ;
0 · Reply
Timefortendies77
Timefortendies77 Nov. 13 at 11:55 PM
$BHVN I'm in after MDD and before Epilepsy read out.
1 · Reply
Timefortendies77
Timefortendies77 Nov. 13 at 11:54 PM
$BHVN Looks like they did a successful raise--so maybe this will hold them over for awhile. Anyone estimate what this does with the cash burn? We can make it through Epilepsy trials?
1 · Reply
Reneejordan001
Reneejordan001 Nov. 13 at 10:11 PM
$BHVN Offering is closed!!
0 · Reply
BapoRothstein
BapoRothstein Nov. 13 at 9:02 PM
$BHVN Lol. My cost is sub 8.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 7:42 PM
Citigroup updates rating for Biohaven ( $BHVN ) to Buy, target set at 28 → 14.
0 · Reply
GregoryGains
GregoryGains Nov. 13 at 6:15 PM
Smol position in $PFE and $BHVN
0 · Reply
BapoRothstein
BapoRothstein Nov. 13 at 3:59 AM
$BHVN Do you think it will get Phase 2 top-line data for opakalim before end of year?
2 · Reply
EvBullforever13
EvBullforever13 Nov. 13 at 3:02 AM
$BHVN $QBTS $SPRB $SRPT CEO sold out… It’s over for now, will check back in 2045
1 · Reply
GregoryGains
GregoryGains Nov. 13 at 1:19 AM
$BHVN interesting to see how this one plays out!
0 · Reply
BapoRothstein
BapoRothstein Nov. 12 at 8:50 PM
$BHVN Holding up nicely in spite of offering. I always get interested when a beaten down stock does an offering and doesn’t get murdered. Usually a reliable sign that the intermediate bottom is in.
0 · Reply
fredbull
fredbull Nov. 12 at 7:18 PM
$BHVN they just added cash to their vault, to survive till a premium buyout. This is going over $10 in a week imo
1 · Reply
Markinoh
Markinoh Nov. 12 at 5:40 PM
$BHVN How long will $175M keep them going?
1 · Reply
DoctorEmmettBrown
DoctorEmmettBrown Nov. 12 at 4:30 PM
$BHVN The raise reduces financial risk…it doesn’t increase debt. Anyone saying “this proves theyre drowning in debt” is just wrong. After the deal closes biohaven will have more cash, the same debt, and a longer runway
0 · Reply
ModeWolfOfMainStreet
ModeWolfOfMainStreet Nov. 12 at 3:07 PM
$BHVN I thought this was supposed to be 5$ at open today? 🤔
1 · Reply
Ralphbeach
Ralphbeach Nov. 12 at 2:38 PM
$BHVN follow all the recent buyouts. Offerings taken place before the buyouts. The cash is the 🍒. RNA 9 2025 offering. Buyout Novartis Kronos bio Channel ther. The list goes on... .
0 · Reply
Pika_Capital
Pika_Capital Nov. 12 at 2:36 PM
$BHVN got 1k shares. Extremely oversold plus raising cash now
0 · Reply